WallStreetZenWallStreetZen

NASDAQ: BDTX
Black Diamond Therapeutics Inc Earnings & Revenue

BDTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$82.4M
Current Profit Margin
0%

BDTX Return on Equity

Current Company
-76.4%
Current Industry
-63.4%
Current Market
188%
BDTX's Return on Equity (-76.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BDTX announces earnings.

BDTX Return on Assets

Current Company
-56.2%
Current Industry
3.2%
BDTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BDTX Return on Capital Employed

Current Company
-59.34%
Current Industry
19.9%
BDTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BDTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BDTX$0.00-$82.01M-$82.44MN/AN/A
FGEN$147.75M-$258.77M-$284.23M-7.05%N/A
CRDF$488.00k-$41.04M-$41.47M+5.22%N/A
GLSI$0.00-$8.93M-$8.94MN/AN/A
QURE$15.84M-$253.10M-$308.48M+7.02%N/A

BDTX earnings dates

Next earnings date
May 7, 2024

Black Diamond Therapeutics Earnings & Revenue FAQ

What were BDTX's earnings last quarter?

On Invalid Date, Black Diamond Therapeutics (NASDAQ: BDTX) reported Q4 2023 earnings per share (EPS) of -$0.34, up 42.37% year over year. Total Black Diamond Therapeutics earnings for the quarter were -$19.41 million. In the same quarter last year, Black Diamond Therapeutics's earnings per share (EPS) was -$0.59.

If you're new to stock investing, here's how to buy Black Diamond Therapeutics stock.

What was BDTX's earnings growth in the past year?

As of Q1 2024, Black Diamond Therapeutics's earnings has grown year over year. Black Diamond Therapeutics's earnings in the past year totalled -$82.44 million.

What is BDTX's earnings date?

Black Diamond Therapeutics's earnings date is Invalid Date. Add BDTX to your watchlist to be reminded of BDTX's next earnings announcement.

What was BDTX's revenue last quarter?

On Invalid Date, Black Diamond Therapeutics (NASDAQ: BDTX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Black Diamond Therapeutics's revenue was $0.00.

What was BDTX's revenue growth in the past year?

As of Q1 2024, Black Diamond Therapeutics's revenue has grown null year over year. Black Diamond Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.